A Question That Has Changed Since the Early Days of the Pandemic
When COVID-19 first appeared, one of the biggest questions facing parents was simple but difficult:
Should children be vaccinated against COVID-19?
At the beginning of the pandemic, scientists had limited information about how the virus affected younger age groups. As research expanded, vaccines were studied in children and adolescents, regulatory agencies reviewed the evidence, and recommendations evolved.
Today, the conversation looks very different.
COVID-19 vaccines are no longer a brand-new technology being tested for the first time in children. Vaccines have been studied and used in younger age groups for years, while health authorities continue to monitor their safety and effectiveness.
However, that does not mean that every child automatically needs the same vaccine schedule.
In the United States, for example, current CDC guidance recommends a 2025–2026 COVID-19 vaccine for people aged 6 months and older based on individual decision-making. The benefit is considered particularly important for people at higher risk of severe COVID-19.
So what should parents actually know?
What Happened With the Pfizer-BioNTech Vaccine?
Back in 2021, Pfizer and BioNTech announced results from a clinical trial involving children between 5 and 11 years old.
The trial included 2,268 children. Participants received two doses of the vaccine 21 days apart, with each dose containing 10 micrograms—one-third of the dose used at that time for people aged 12 and older.
Researchers reported that the children developed an immune response comparable to that observed in the older comparison group.
At the time, these results were significant because they represented an important step toward making COVID-19 vaccination available to younger children.
But it is important to understand the historical context.
Those results were not the final word on COVID-19 vaccination in children. They were part of an evolving body of evidence that continued to be reviewed as new variants emerged, vaccine formulations changed, and researchers collected additional safety and effectiveness information.
The vaccines available today are not simply identical to the original 2021 formulations.
How COVID-19 Vaccination Has Changed
One of the most important things parents should understand is that COVID-19 vaccination recommendations have evolved.
The original vaccines were designed against the virus that circulated during the earliest stages of the pandemic.
As SARS-CoV-2 changed, updated vaccines were developed to better match circulating variants.
The FDA has explained that COVID-19 vaccines for the 2025–2026 season were updated toward a monovalent JN.1-lineage formulation, with LP.8.1 preferred as the strain used for vaccine composition.
That means an article written in 2021 can be misleading if it is presented as though it describes today's vaccination schedule.
The scientific evidence has continued to develop.
Can Young Children Receive a COVID-19 Vaccine?
Yes, COVID-19 vaccines have been available for young children in the United States.
The FDA's current information for parents states that children 6 months through 11 years of age may receive either the Moderna COVID-19 Vaccine or the Pfizer-BioNTech COVID-19 Vaccine, depending on the applicable product and recommendations.
However, there is an important distinction between saying a vaccine is available for an age group and saying every child should receive it under exactly the same circumstances.
Current recommendations can depend on:
The child's age
Previous COVID-19 vaccination
Previous infection
Underlying medical conditions
Immune status
The vaccine formulation available
The recommendations of the country where the child lives
This is why parents should not rely on an old social-media post, article, or screenshot when deciding whether their child needs a dose.
Why Does Individual Risk Matter?
COVID-19 does not affect every child in exactly the same way.
Many healthy children who become infected experience mild illness, but some children can develop serious complications.
The risk of severe disease is generally higher in people with certain underlying medical conditions or weakened immune systems.
That is one reason modern vaccination policies increasingly emphasize individual risk rather than treating every person as though their situation were identical.
The CDC's current guidance specifically says that the 2025–2026 COVID-19 vaccine is recommended for people 6 months and older through individual-based decision-making.
For families, this means the most useful question may not simply be:
"Does my child qualify by age?"
Instead, parents should also ask:
"What is my child's individual risk, what protection has my child already developed, and what does the current recommendation in my country say?"
What About Healthy Children?
This is where recommendations can become more nuanced.
The World Health Organization says that revaccination is not routinely recommended for healthy children and adolescents, while children and adolescents at higher risk of severe COVID-19 may benefit from vaccination according to national policies and circumstances.
This does not mean that COVID-19 vaccination is considered unsafe for healthy children.
Rather, it reflects the fact that the balance between potential benefit and risk can be different for a healthy child than for someone who has a condition that increases the likelihood of severe disease.
Health authorities therefore consider several factors rather than relying on age alone.
Are COVID-19 Vaccines Still Effective?
Vaccines are not a guarantee that someone will never become infected.
That distinction is extremely important.
COVID-19 vaccines have evolved partly because the virus itself has evolved.
Current vaccines are primarily intended to reduce the risk of severe outcomes rather than provide perfect protection against every infection.
The WHO notes that real-world evidence continues to show that COVID-19 vaccines reduce COVID-19-associated severe disease and death, while protection against infection can change as the virus evolves.
This is similar to many other respiratory-virus vaccines: protection can be strongest against severe disease even when infections can still occur.
So if a vaccinated child later tests positive for COVID-19, that does not automatically mean the vaccine "failed."
The goal of vaccination is broader than preventing every positive test.
What Side Effects Can Children Experience?
Like other vaccines, COVID-19 vaccines can cause temporary side effects.
Common reactions may include:
Pain or tenderness where the injection was given
Tiredness
Headache
Muscle aches
Chills
Fever
Feeling generally unwell
These reactions usually resolve within a short period.
Parents should always read the current vaccine information provided with the specific product their child receives.
There are also uncommon but important adverse events that health authorities continue to monitor.
For mRNA COVID-19 vaccines, myocarditis and pericarditis have been identified as rare risks, particularly in adolescent and young adult males. Updated FDA safety information includes warnings concerning these events.
This is precisely why vaccine safety monitoring continues even after a vaccine has been authorized or approved.
What Does "FDA Approved" Actually Mean?
Another source of confusion is the difference between emergency authorization and full approval.
During the early stages of the pandemic, COVID-19 vaccines were frequently discussed under Emergency Use Authorization terminology.
Over time, regulatory status has changed.
The FDA states that the original Pfizer-BioNTech COVID-19 Vaccine's Emergency Use Authorization was revoked in August 2025, while Comirnaty remains an FDA-approved Pfizer COVID-19 vaccine.
The FDA's current Comirnaty information says that the vaccine is approved for people aged 65 and older, as well as people aged 5 through 64 who have at least one underlying condition that places them at higher risk of severe COVID-19 outcomes.
This is another reason older articles can quickly become outdated.
Why Parents Should Be Careful With Old COVID Articles
If you've seen an article online claiming:
"Pfizer says its vaccine is safe for children aged 5 to 11!"
you should check the publication date.
If the article was written in September 2021, it is describing the scientific and regulatory situation of that particular moment.
It may contain accurate information about what researchers knew then, but it should not automatically be treated as current medical guidance.
Since 2021:
New COVID-19 variants have emerged.
Vaccine formulations have changed.
More safety data have accumulated.
More children have developed immunity through vaccination or infection.
Regulatory approvals have changed.
National vaccination policies have changed.
Public-health priorities have evolved.
In other words, old COVID-19 headlines can be historically interesting without being medically current.
What About the Delta Variant?
The original article also focused heavily on the Delta variant.
That made sense in 2021.
Delta was associated with major waves of COVID-19 infections and increased hospitalizations, including among children and adolescents.
But Delta is no longer the dominant context for today's COVID-19 vaccination decisions.
SARS-CoV-2 has continued to evolve, and vaccine composition has been updated accordingly.
Therefore, parents should be skeptical of articles that use the Delta variant as though it were the current reason to vaccinate children.
A headline may sound urgent because it was written during a completely different stage of the pandemic.
Should Parents Vaccinate Their Child?
There isn't one universal answer that applies identically to every child in every country.
Instead, parents should consider the child's personal situation and the recommendations of their local health authority.
Important questions include:
Does my child have a medical condition that increases the risk of severe COVID-19?
Has my child already received COVID-19 vaccines?
When was the most recent dose?
Has my child previously had COVID-19?
Which vaccine formulation is currently available?
What does my country's current vaccination guidance recommend?
These questions are far more useful than relying on a viral post written several years ago.
What Should Parents Do Before Vaccination?
If you are considering COVID-19 vaccination for your child, speak with a pediatrician, family doctor, pharmacist, or another qualified healthcare professional.
Bring information about:
Previous COVID-19 vaccinations
Previous COVID-19 infection
Allergies
Current medications
Existing medical conditions
Previous reactions to vaccines
The healthcare professional can help determine whether vaccination is appropriate and which schedule applies.
Do not use an old article to calculate your child's dose or vaccination interval.
Those details can change depending on the vaccine product, age, vaccination history, and current recommendations.
A Balanced Look at the Question
Parents deserve clear information—not fear, pressure, or exaggerated promises.
It is reasonable to ask questions about vaccine benefits.
It is also reasonable to ask about side effects.
Good medical decisions do not require pretending that vaccines have zero risks.
Instead, the goal is to compare the known benefits and potential risks for a particular person.
For a child at increased risk of severe COVID-19, the potential benefit of vaccination may be particularly important.
For a healthy child at relatively low risk, the decision may require a more individualized discussion.
That is why current guidance increasingly emphasizes shared or individual decision-making.
The Bottom Line
The question "Should children under 12 get the COVID-19 vaccine?" cannot be answered accurately by simply repeating a 2021 headline.
The situation has changed.
COVID-19 vaccines have been studied in children, updated formulations have been developed, and health authorities continue to monitor safety and effectiveness.
In the United States, current CDC guidance for the 2025–2026 season recommends COVID-19 vaccination for people aged 6 months and older based on individual-based decision-making.
The FDA also continues to provide current information on vaccine products and their approved or authorized uses.
Meanwhile, WHO guidance emphasizes that healthy children and adolescents do not necessarily need routine revaccination, while vaccination can be particularly important for those at higher risk of severe disease.
So before sharing that old headline or making a decision based on it, stop and ask one simple question:
"Is this information still current?"
With COVID-19, that question matters more than ever.
This article is for general informational purposes only and is not a substitute for medical advice. COVID-19 vaccination recommendations can vary by country, age, health status, vaccine product, and vaccination history. Parents should consult a qualified healthcare professional or their local public-health authority for advice specific to their child.
0 commentaires:
Enregistrer un commentaire